Brokerages forecast that Tyme Technologies Inc (NASDAQ:TYME) will report earnings per share of ($0.06) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Tyme Technologies’ earnings. Tyme Technologies posted earnings per share of ($0.08) during the same quarter last year, which suggests a positive year over year growth rate of 25%. The business is scheduled to issue its next quarterly earnings results on Monday, February 10th.
According to Zacks, analysts expect that Tyme Technologies will report full year earnings of ($0.21) per share for the current year. For the next fiscal year, analysts forecast that the company will report earnings of ($0.23) per share. Zacks’ earnings per share calculations are an average based on a survey of analysts that follow Tyme Technologies.
Tyme Technologies (NASDAQ:TYME) last posted its quarterly earnings results on Monday, November 4th. The company reported ($0.04) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.02.
In related news, major shareholder Michael Demurjian sold 20,000 shares of the company’s stock in a transaction on Monday, September 23rd. The shares were sold at an average price of $1.67, for a total value of $33,400.00. Insiders sold 260,000 shares of company stock valued at $2,175,600 over the last quarter. 27.17% of the stock is currently owned by corporate insiders.
A number of large investors have recently modified their holdings of TYME. Squarepoint Ops LLC bought a new stake in Tyme Technologies in the third quarter worth $71,000. Morgan Stanley boosted its holdings in Tyme Technologies by 187.8% during the second quarter. Morgan Stanley now owns 139,579 shares of the company’s stock valued at $170,000 after acquiring an additional 91,081 shares during the period. Perkins Capital Management Inc. boosted its holdings in Tyme Technologies by 77.0% during the third quarter. Perkins Capital Management Inc. now owns 142,500 shares of the company’s stock valued at $170,000 after acquiring an additional 62,000 shares during the period. Paloma Partners Management Co bought a new stake in Tyme Technologies during the second quarter valued at about $238,000. Finally, Bank of New York Mellon Corp boosted its holdings in Tyme Technologies by 5.9% during the second quarter. Bank of New York Mellon Corp now owns 306,199 shares of the company’s stock valued at $374,000 after acquiring an additional 17,173 shares during the period. Hedge funds and other institutional investors own 12.93% of the company’s stock.
Shares of NASDAQ TYME traded up $0.03 during mid-day trading on Wednesday, reaching $1.15. The company had a trading volume of 189,100 shares, compared to its average volume of 621,117. Tyme Technologies has a twelve month low of $0.92 and a twelve month high of $4.64. The stock has a market capitalization of $125.38 million, a PE ratio of -3.59 and a beta of 0.34. The stock’s 50 day moving average is $1.25 and its 200-day moving average is $1.24.
About Tyme Technologies
Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.